Crescita Therapeutics (TSE:CTX) Reaches New 12-Month High – Here’s What Happened

Crescita Therapeutics Inc. (TSE:CTX) shares hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as C$0.75 and last traded at C$0.74, with a volume of 390296 shares changing hands. The stock had previously closed at C$0.73.

Crescita Therapeutics Stock Up 1.4%

The company has a debt-to-equity ratio of 2.98, a current ratio of 3.12 and a quick ratio of 2.29. The business’s 50 day simple moving average is C$0.49 and its 200 day simple moving average is C$0.47. The company has a market capitalization of C$13.77 million, a PE ratio of 37.00 and a beta of -0.39.

Crescita Therapeutics Company Profile

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.